Oppenheimer analyst, Steven Lichtman, reiterated his Outperform rating on shares of Tandem Diabetes Care (NASDAQ: TNDM) and raised his price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE